J Nutr Health.  2013 Dec;46(6):540-551.

Prevalence of vitamin D deficiency in Korea: Results from KNHANES 2010 to 2011

• Jung IK

Abstract

Vitamin D deficiency (VDD) is becoming an epidemic and thereby a global health problem. Further, VDD adversely affects calcium metabolism and skeletal health, and is associated with increased risk of several diseases, e.g., autoimmune diseases, several types of cancers, type 2 diabetes mellitus, cardiovascular diseases, infectious diseases, asthma, psoriatic arthritis, and etc. To evaluate the prevalence of VDD in Korea, and then to evaluate the association of several factors with serum 25(OH)D level, the author analyzed the data of 14,456 individuals who were 10 years of age and over from the Fifth Korea National Health and Nutrition Examination Survey 1 & 2 (KNHANES V-1 & 2) conducted by the Korean Centers for Disease Control & Prevention. As a result, among Koreans (age >== 10years), 65.9% of males and 77.7% of females were below optimum blood serum 25(OH)D (20 ng/mL). VDD is more severe in female than in male at all age groups. In addition, the younger generations had less 25(OH)D level than older generations in Korea. The analysis by complex sample general linear model (CSGLM) suggested that blood 25(OH)D concentration was related with gender (p < .001), residence (p = .030), occupation (p < .001), anemia (p < .001) and physical activity (p < .001). In conclusion, VDD is pandemic and it is more severe in younger generations in Korea. Further, from the results by CSGLM, serum 25(OH)D status is closely related with the life style of Koreans.

Keyword

vitamin D; VDD; 25(OH)D; life style; KNHANES

MeSH Terms

Anemia
Arthritis, Psoriatic
Asthma
Autoimmune Diseases
Calcium
Cardiovascular Diseases
Centers for Disease Control and Prevention (U.S.)
Communicable Diseases
Diabetes Mellitus, Type 2
Family Characteristics
Female
Humans
Korea*
Life Style
Linear Models
Male
Metabolism
Motor Activity
Nutrition Surveys
Occupations
Pandemics
Prevalence*
Serum
Vitamin D Deficiency*
Vitamin D*
Vitamins*
Calcium
Vitamin D
Vitamins

Reference

References

1). Christodoulou S, Goula T, Ververidis A, Drosos G. Vitamin D and bone disease. Biomed Res Int. 2013; 2013:396541.

2). Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3):266–281.

3). Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29(6):726–776.

4). Wacker M, Holick MF. Vitamin D – effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013; 5(1):111–148.

5). Pekkinen M, Viljakainen H, Saarnio E, Lamberg-Allardt C, Mäki-tie O. Vitamin D is a major determinant of bone mineral density at school age. PLoS One. 2012; 7(7):e40090.

6). Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardel-lone P, Gandini S, Gruson D, Guérin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010; 9(11):709–715.

7). Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, Scragg R, Volpe SL, Witham MD, Giaccari A. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis. 2012; 22(2):81–87.

8). Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A, Cavalier E, Pieber TR, Lappe JM, Grant WB, Holick MF, Dekker JM. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2011; 75(5):575–584.

9). Kienreich K, Tomaschitz A, Verheyen N, Pieber T, Gaksch M, Grübler MR, Pilz S. Vitamin D and cardiovascular disease. Nutrients. 2013; 5(8):3005–3021.

10). Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012; 3(6):181–187.

11). Chitsaz A, Maracy M, Basiri K, Izadi Boroujeni M, Tanhaei AP, Rahimi M, Meamar R. 25-hydroxyvitamin d and severity of Parkinson's disease. Int J Endocrinol. 2013; 2013:689149.

12). Crane-Godreau MA, Black CC, Giustini AJ, Dechen T, Ryu J, Ju-kosky JA, Lee HK, Bessette K, Ratcliffe NR, Hoopes PJ, Fiering S, Kelly JA, Leiter JC. Modeling the influence of vitamin D deficiency on cigarette smoke-induced emphysema. Front Physiol. 2013; 4:132.

13). Holgate ST. The epidemic of asthma and allergy. J R Soc Med. 2004; 97(3):103–110.

14). Kheradmand F, Rishi K, Corry DB. Environmental contributions to the allergic asthma epidemic. Environ Health Perspect. 2002; 110(Suppl 4):553–556.

15). Gupta D, Vashi PG, Trukova K, Lis CG, Lammersfeld CA. Prevalence of serum vitamin D deficiency and insufficiency in cancer: review of the epidemiological literature. Exp Ther Med. 2011; 2(2):181–193.

16). Kinder BW, Hagaman JT. Could combating vitamin D deficiency reduce the incidence of autoimmune disease? Expert Rev Clin Immunol. 2011; 7(3):255–257.

17). Laway BA. Vitamin D deficiency and youth-onset diabetes in North India. Arq Bras Endocrinol Metabol. 2013; 57(2):159–160.

18). Chakhtoura M, Azar ST. The role of vitamin D deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. Int J Endocrinol. 2013; 2013:148673.

19). Gunville CF, Mourani PM, Ginde AA. The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets. 2013; 12(4):239–245.

20). Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5(7):2502–2521.

21). Sadat-Ali M, Al Elq A, Al-Farhan M, Sadat NA. Fortification with vitamin D: comparative study in the Saudi Arabian and US markets. J Family Community Med. 2013; 20(1):49–52.

22). Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87(4):1080S–1086S.

23). Moan J, Porojnicu AC, Dahlback A, Setlow RB. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci U S A. 2008; 105(2):668–673.

24). Gonzalez H, Tarras-Wahlberg N, Strömdahl B, Juzeniene A, Moan J, Larkö O, Rosén A, Wennberg AM. Photostability of commercial sunscreens upon sun exposure and irradiation by ultraviolet lamps. BMC Dermatol. 2007; 7:1.

25). Nair R, Maseeh A. Vitamin D: The “sunshine” vitamin. J Pharmacol Pharmacother. 2012; 3(2):118–126.

26). Visweswaran RK, Lekha H. Extraskeletal effects and manifestations of vitamin D deficiency. Indian J Endocrinol Metab. 2013; 17(4):602–610.

27). Hochberg Z, Templeton AR. Evolutionary perspective in skin color, vitamin D and its receptor. Hormones (Athens). 2010; 9(4):307–311.

28). Guessous I, Dudler V, Glatz N, Theler JM, Zoller O, Paccaud F, Burnier M, Bochud M. Swiss Survey on Salt Group. Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Med Wkly. 2012; 142:w13719.

29). Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, Kim KJ, Rhee Y, Lim SK. Vitamin D insufficiency in Koreaa greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab. 2011; 96(3):643–651.

30). Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Cheongwon: Korea Centers for Disease Control and Prevention;2011.

31). Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2011: Korea National Health and Nutrition Examination Survey (KNHANES V-2). Cheongwon: Korea Centers for Disease Control and Prevention;2012.

32). Weisman Y. Vitamin D deficiency and insufficiency. Isr Med Assoc J. 2013; 15(7):377–378.

33). Haddad JG Jr, Rojanasathit S. Acute administration of 25-hy-droxycholecalciferol in man. J Clin Endocrinol Metab. 1976; 42(2):284–290.

34). Stamp TC, Round JM, Rowe DJ, Haddad JG. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br Med J. 1972; 4(5831):9–12.

35). Birge SJ, Haddad JG. 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest. 1975; 56(5):1100–1107.

36). Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011; 86(1):50–60.

37). Naugler C, Zhang J, Henne D, Woods P, Hemmelgarn BR. Association of vitamin D status with sociodemographic factors in Calgary, Alberta: an ecological study using Census Canada data. BMC Public Health. 2013; 13:316.

38). Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2000; 85(11):4125–4130.

39). Sulistyoningrum DC, Green TJ, Lear SA, Devlin AM. Ethnic-specific differences in vitamin D status is associated with adiposity. PLoS One. 2012; 7(8):e43159.

40). Sacheck J, Goodman E, Chui K, Chomitz V, Must A, Economos C. Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren. J Pediatr. 2011; 159(6):945–950.

41). Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab. 2011; 96(5):1560–1567.

42). Khor GL, Chee WS, Shariff ZM, Poh BK, Arumugam M, Rahman JA, Theobald HE. High prevalence of vitamin D insufficiency and its association with BMI-for-age among primary school children in Kuala Lumpur, Malaysia. BMC Public Health. 2011; 11:95.

43). Shahar DR, Schwarzfuchs D, Fraser D, Vardi H, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ, Shai I. DIRECT Group. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr. 2010; 92(5):1017–1022.

44). Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P, Krassas GE. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab. 2010; 95(9):4251–4257.

45). Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009; 29(9):3713–3720.

46). Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Jan-neh M, Reynolds J, Yanovski JA. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004; 89(3):1196–1199.

47). Absoud M, Cummins C, Lim MJ, Wassmer E, Shaw N. Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study. PLoS One. 2011; 6(7):e22179.

48). Shirazi L, Almquist M, Malm J, Wirfält E, Manjer J. Determinants of serum levels of vitamin D: a study of lifestyle, menopausal status, dietary intake, serum calcium, and PTH. BMC Womens Health. 2013; 13(1):33.